I would just hope that we are not looking at this from an ideological point of view, which the President is trying to achieve.

The rhetoric around these issues have become like watching the opening of an old television show, waiting to get to the main programming.

While I am pleased that the subcommittee has decided to conduct continued oversight of the Cures Act, there are several topics within the subcommittee's jurisdiction that also deserve hearings and oversight.

I want to thank our colleagues Diana DeGette and Fred Upton, without which the Cures Act would never have become law.

I want to commend the commission for the decision to lift the cap on the rural health telemedicine piece.

If the agency was serious about focusing on consumers, it would want to help parents searching for quality educational programming and shield children, not make them easier targets for big business.

Last week, FDA announced the release of its biosimilar action plan, which strives to encourage more innovation and competition in the biologics market.

Since the FCC is shirking its responsibility, Congress should be conducting more oversight in the future.

It is our duty to ensure the Commission's actions advance those goals and hold the Chairman and Commissioners accountable when the agency does not.

We sit here and listen to the same old falsehoods that we ripped away privacy and net neutrality protections.

The FCC should be looking for ways to help these struggling participants in our economy and community and not just cut them off.

Unfortunately, the Republican majority of this committee has been unwilling to follow through on its promise to hold quarterly oversight hearings with the FCC.